Publications & Reports
Find Publications by Keyword, Topic, or Author
Search all publications by keyword
Browse by Topic:
American Indians / Alaska Natives
Cannabis
Harm reduction
HIV/AIDS/Sexual Risk Behavior
Gender/LGBTQ+
Stimulants (methamphetamine, cocaine)
Opioids/Overdose Prevention
Pregnant & Parenting Women/FASD
Treatment
State & County Drug Trends
Youth/Young Adults/College
Search by ADAI Author
Recent Publications & Presentations
Need help getting a copy of an ADAI publication? Email ADAI’s Director of Information Services Meg Brunner, MLIS: meganw@uw.edu.

Cannabis-related problems, adverse events, clinical experiences and barriers to intervening: Perspectives of health care providers in Washington State.
Carlini BH, Kellum LB, Garrett SB, Williams JR.
Substance Use & Addiction 2026 (in press).

“You’re doing it because your freedom is on the line”: a qualitative study exploring how people who use opioids and methamphetamine navigate legal involvement and carceral treatment for substance use disorder.
Iacobelli NP, Estrella L, Owens MD, et al.
Harm Reduction Journal 2026 (in press).

People with psychotic disorders are the most vulnerable to cannabis adverse health outcomes: A study in WA State, USA.
Carlini BH, Williams JR, Garrett SB, Hammond D.
Community Mental Health Journal 2026 (in press).

Exploring THC labelling preferences to communicate the strength of cannabis products: Insights from U.S. consumers.
Dawson D, Hall W, Goodwin I, Carlini BH, Lubman DI, Hammond D, Freeman TP, Lorenzetti V.
International Journal of Drug Policy 2026;147:105076.

Integrating a brief behavioral intervention into case management for mothers with perinatal substance use disorder: Nonrandomized pilot feasibility study.
Bhat A, Curran MC, Lohr MJ, Smith H, Blanchard B, Stoner SA, Grant T, Grote N.
JMIR Formative Research 2025;9:e75132.

Predicting willingness to use MOUD: An application of the theory of reasoned action and theory of planned-behavior.
Lancaster C, Laschober TC, Nelson CM, Hatch MA, Paschen-Wolff MM, Ertl MM, Wright L, Tross S.
Journal of Drug Issues 2025 (in press).

Attitudes about alcohol misuse among Alaska Native people in a Tribal health care system.
Dillard DA, Hebert LE, Dirks LG, Shaw JL, Trinidad SB, Lillie K, Donovan DM, Burke W, Ludman EJ.
Journal of Addiction Medicine 2025 (in press).

“PrEP is Always on the Table”: Mixed Methods Study of Provider Willingness to Refer/Link Clients to PrEP in Community Sexual Health and Drug Use-Related Programs.
Paschen-Wolff MM, Laschober TC, Spector AY, Ertl MM, Nelson CM, Hatch MA, Lancaster C, Wright L, Tross S.
Journal of HIV/AIDS & Social Services 2025 (in press).

Fentanyl, methamphetamine and polysubstance use differentially affect locomotor sensitisation and social behaviour in rats: Psychedelic treatment reverses social deficits.
Salinsky LM, Diaz KC, Fox JL, Panh SM, Ferguson SM.
Addiction Biology 2026;31(3):e70132.

There and back again: Continuing efforts via regional partnership to promote workforce awareness of scientific advancements in addiction care.
Hartzler B, Brunner M, Fokuo JK, Ostacher MJ, Pagano A, Rutkowski BA, Vest RA, Masson CL.
Journal of Substance Use and Addiction Treatment 2026 (in press).

Evaluation of the City of Seattle Ordinance 126896 on Controlled Substances: Final Report [to the Seattle Office of Inspector General].
Owens MD.
Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, December 2025.

Future pandemic preparedness: conceptualizing vaccine willingness in drug-using populations during COVID-19 in Southeastern U.S. cities.
Orozco K, Laschober TC, Tross S, Ertl MM, Paschen-Wolff MM, Nelson CM, Lancaster C, Hatch MA.
Journal of HIV/AIDS & Social Services 2025 (in press).

Examining removal of federal waiver restrictions to prescribing buprenorphine in primary care.
Simon CB, Hus C, Prado MG, Kwun CGC, LeMaster JW, Hatch MA, Tong ST, Stephens KA.
Journal of the American Board of Family Medicine 2025;38(3):752-756.

Reason to expand the contingency management workforce: Coaching-to-criterion results for addiction professionals and peer specialists.
Hartzler B, Peng L, Cooke A, Kunkel L, Stack E, Leahy J, Cook R, Hildegran C, Hoffman K, Verbeck J, Nugent M, Leightling G, Smith Payne K, McIlveen JW, Korthuis PT.
Substance Use & Addiction Journal 2025 (in press).

Kratom & 7-OH: What do we know about use, safety, and overdose risk?
Sladky M & Banta-Green C.
Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2025.
